A Randomized Controlled Trial Comparing Rabeprazol with Esomeprazol in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers

A Randomized Controlled Trial Comparing Rabeprazol with Esomeprazol in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers - A Randomized Controlled Trial Comparing Rabeprazol with Esomeprazol in Post ESD gastric ulcer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024002

Enrollment

Registered

2016-09-12

Start date

2013-01-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric tumor

Interventions

Rabeprazole Esomeprazole

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gastric neoplasm treated by Clutch Cutter ESD Single Operater Patient's agreement

Exclusion criteria

Exclusion criteria: Without above criteria

Design outcomes

Primary

Measure	Time frame
Scarring rate of gastric ulcer Quality of ulcer healing Complication	—

Countries

Japan

Contacts

Public ContactKazuya Akahoshi

Aso Iizuka Hospital Department of Gastroenterology

kakahoshi2@aol.com0948-22-3800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026